Healthcap
Stockholm · healthcap.eu
- Pharma/Biotech
HealthCap is a Stockholm-based life science venture firm investing in targeted therapies for rare diseases, cancers and genetic diseases.
Raising a round? See which funds fit your startup. Your #1 match is free. No signup, no card.
Updated · Sources: fund website
Would Healthcap back you?
Overview
Healthcap at a glance
Healthcap is a Series A to Pre Exit venture capital firm based in Stockholm that invests in Pharma/Biotech, Therapeutics and Cell Therapy. Partners at Healthcap include Alex Valcu (Partner) and Anki Forsberg (Partner and Chairman).
- Stage
- Series A, Series B, Series C, Clinical, Pre Exit
- Sectors
- Pharma/Biotech, Therapeutics, Cell Therapy, Oncology
- Headquarters
- Stockholm
- Cold inbound
- Warm intro preferred
- Website
- healthcap.eu
Investment thesis
HealthCap invests in innovative life science companies developing targeted therapies for rare diseases, cancers, and genetic diseases with high unmet medical need to impact healthcare and society.
Stated on healthcap.euWEBSITE
What sets Healthcap apart
- Medical expertise embedded in team (medicine, finance, biochemistry backgrounds)
- 28+ year track record with 34 approved drugs and 48 IPOs
- Focus on portfolio company creation not just investment
- Active role in European life sciences ecosystem and coalitions
What the portfolio shows
Portfolio 3
Backed: Vicore Pharma, Aprea Therapeutics, Adcendo ApS
Partners
19 partners at Healthcap
- Alex Valcu
Partner
- Anki Forsberg
Partner and Chairman
- Björn Odlander
Managing Partner
- Carl Kilander
Partner
- Carl-Johan Dalsgaard
Venture Partner
- Daniel Karsberg
Partner
- Eugen Steiner
Venture Partner
- Georg Vo Beiske
Venture Partner
- Johan Christenson
Partner
- Josefine Persson
Associate
- Kristina Ekberg
Partner
- Mårten Steen
Managing Partner
- Max Odlander
Partner
- Nikolai Paus
Associate
- Nima Barati
Medical Associate
- Per Samuelsson
Partner
- Shamim Dadvar
Associate
- Staffan Lindstrand
Partner
- Tyra Küller
Associate
Similar funds
Funds like Healthcap
Investor lists that include Healthcap
FAQ
Questions about Healthcap
What does Healthcap invest in?
Healthcap is a Series A, Series B, Series C, Clinical, Pre Exit stage Pharma/Biotech, Therapeutics, Cell Therapy, Oncology investor, primarily investing in Europe. Their thesis: HealthCap invests in innovative life science companies developing targeted therapies for rare diseases, cancers, and genetic diseases with high unmet medical need to impact healthcare and society.
What makes Healthcap different from other funds?
Healthcap stands out on 4 points: Medical expertise embedded in team (medicine, finance, biochemistry backgrounds); 28+ year track record with 34 approved drugs and 48 IPOs; Focus on portfolio company creation not just investment; Active role in European life sciences ecosystem and coalitions.
How do I reach Healthcap?
Healthcap does not generally take cold inbound; a warm introduction from a founder or investor the firm knows is the usual path.
Sources
- Website: Healthcap website (healthcap.eu)
- Method: How DryPowder builds its data
Updated